Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate for Tibial Fractures
Tibial Fracture - Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate (T-PAC): A Randomized Controlled Feasibility Study
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Forty-five patients with unilateral closed tibial diaphyseal fractures were randomized to receive either platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) with standard care or standard care alone. Primary outcomes of interest were time to painless weight bearing, radiological union (2, 8, 12, 16, 20, 26, and 39 weeks), and patient-reported outcome measures (0, 12, 26, and 39 ...
Join the Conversation
Please Login or Join to leave comments.